Investigation of the Efficacies of a Resveratrol Formula on Improvement of

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06002685` - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention	N/A
Recruiting	`NCT06202274` - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology	N/A
Completed	`NCT01899287` - A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand Eczema	N/A
Completed	`NCT01467778` - Safety Study of Three Formulations of the Dermal Implant ELAPR	Phase 1

See also

Status

Clinical Trial

Phase

Recruiting

NCT06002685 - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention

N/A

Recruiting

NCT06202274 - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

N/A

Completed

NCT01899287 - A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand Eczema

N/A

Completed

NCT01467778 - Safety Study of Three Formulations of the Dermal Implant ELAPR

Phase 1

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04456829
Study type	Interventional
Source	TCI Co., Ltd.
Contact
Status	Completed
Phase	N/A
Start date	September 17, 2020
Completion date	December 31, 2020

Investigation of the Efficacies of a Resveratrol Formula on Improvement of Skin Conditions and Inflammatory Related Factors — Resveratrol

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms